Pacific Biosciences of California (PACB) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.78
• Market Cap: $492.11M
• EPS: $-1.82
• 52-Week High: $2.73
• 52-Week Low: $0.85

Market Sentiment

Pacific Biosciences of California currently has a Bullish sentiment score of 0.37.

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. (PACB) is a leading biotechnology company based in Menlo Park, California, specializing in cutting-edge genomic sequencing technologies that are revolutionizing the field. By providing high-resolution sequencing systems, PACB supports a range of applications from genetic research to personalized medicine, catering to the needs of researchers and healthcare professionals alike. With a robust focus on research and development and a growing suite of innova...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pacific Biosciences of California and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PACB pay dividends?

Pacific Biosciences of California (PACB) does not currently pay a regular dividend.

What is PACB's market cap?

Pacific Biosciences of California (PACB) has a market capitalization of $492.11M with a current stock price of $1.78.